Patrick A. Baeuerle
Patrick A. Baeuerle
MPM Capital
Verified email at - Homepage
Cited by
Cited by
Function and activation of NF-kappaB in the immune system
PA Baeuerle, T Henkel
Annual review of immunology 12 (1), 141-179, 1994
Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1.
R Schreck, P Rieber, PA Baeuerle
The EMBO journal 10 (8), 2247-2258, 1991
NF-κB: ten years after
PA Baeuerle, D Baltimore
Cell 87 (1), 13-20, 1996
I kappa B: a specific inhibitor of the NF-kappa B transcription factor
PA Baeuerle, D Baltimore
Science 242 (4878), 540-546, 1988
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.
R Schreck, B Meier, DN Männel, W Dröge, PA Baeuerle
The Journal of experimental medicine 175 (5), 1181-1194, 1992
Nuclear factor kB: an oxidative stress-responsive transcription factor of eukaryotic cells (a review)
R Schreck, KAJ Albermann, PA Baeuerle
Free radical research communications 17 (4), 221-237, 1992
H2O2 and antioxidants have opposite effects on activation of NF‐kappa B and AP‐1 in intact cells: AP‐1 as secondary antioxidant‐responsive factor.
M Meyer, R Schreck, PA Baeuerle
The EMBO journal 12 (5), 2005-2015, 1993
Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor
PA Baeuerle, D Baltimore
Cell 53 (2), 211-217, 1988
The inducible transcription activator NF-κB: regulation by distinct protein subunits
PA Baeuerle
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1072 (1), 63-80, 1991
Rapid proteolysis of I κ B-α is necessary for activation of transcription factor NF-κ B
T Henkel, T Machleidt, I Alkalay, M Krönke, Y Ben-Neriah, PA Baeuerle
Nature 365 (6442), 182-185, 1993
Phosphorylation of human I kappa B‐alpha on serines 32 and 36 controls I kappa B‐alpha proteolysis and NF‐kappa B activation in response to diverse stimuli.
EBM Traenckner, HL Pahl, T Henkel, KN Schmidt, S Wilk, PA Baeuerle
The EMBO journal 14 (12), 2876-2883, 1995
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.
K Brand, S Page, G Rogler, A Bartsch, R Brandl, R Knuechel, M Page, ...
The Journal of clinical investigation 97 (7), 1715-1722, 1996
Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B
MA Collart, P Baeuerle, P Vassalli
Molecular and cellular biology 10 (4), 1498-1506, 1990
Tumor regression in cancer patients by very low doses of a T cell–engaging antibody
R Bargou, E Leo, G Zugmaier, M Klinger, M Goebeler, S Knop, ...
Science 321 (5891), 974-977, 2008
The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product
M Kieran, V Blank, F Logeat, J Vandekerckhove, F Lottspeich, O Le Bail, ...
Cell 62 (5), 1007-1018, 1990
The p65 subunit is responsible for the strong transcription activating potential of NF‐kappa B.
ML Schmitz, PA Baeuerle
The EMBO journal 10 (12), 3805-3817, 1991
Targeted therapy with the T-cell–engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results …
MS Topp, P Kufer, N Gökbuget, M Goebeler, M Klinger, S Neumann, ...
Journal of clinical oncology 29 (18), 2493-2498, 2011
Selective activation of NF-κB by nerve growth factor through the neurotrophin receptor p75
BD Carter, C Kaltschmidt, B Kaltschmidt, N Offenhäuser, ...
Science 272 (5261), 542-545, 1996
Recent advances torwards understanding redox mechanisms in the activation of nuclear factor κb
YMW Janssen-Heininger, ME Poynter, PA Baeuerle
Free Radical Biology and Medicine 28 (9), 1317-1327, 2000
A proteasome inhibitor prevents activation of NF‐kappa B and stabilizes a newly phosphorylated form of I kappa B‐alpha that is still bound to NF‐kappa B.
EB Traenckner, S Wilk, PA Baeuerle
The EMBO journal 13 (22), 5433-5441, 1994
The system can't perform the operation now. Try again later.
Articles 1–20